These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7475271)

  • 1. Aberrant expression of p21RAS but not p120GAP is a common feature of myelodysplasia.
    Gallagher A; Padua RA; al-Sabah A; Hoy T; Burnett AK; Darley RL
    Leukemia; 1995 Nov; 9(11):1833-40. PubMed ID: 7475271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth.
    Skorski T; Kanakaraj P; Ku DH; Nieborowska-Skorska M; Canaani E; Zon G; Perussia B; Calabretta B
    J Exp Med; 1994 Jun; 179(6):1855-65. PubMed ID: 8195713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients.
    Basu TN; Gutmann DH; Fletcher JA; Glover TW; Collins FS; Downward J
    Nature; 1992 Apr; 356(6371):713-5. PubMed ID: 1570015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAS and the myelodysplastic syndromes.
    Gallagher A; Darley R; Padua RA
    Pathol Biol (Paris); 1997 Sep; 45(7):561-8. PubMed ID: 9404480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
    Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
    Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct expression profiles of MSI2 and NUMB genes in myelodysplastic syndromes and acute myeloid leukemia patients.
    Pereira JK; Traina F; Machado-Neto JA; Duarte Ada S; Lopes MR; Saad ST; Favaro P
    Leuk Res; 2012 Oct; 36(10):1300-3. PubMed ID: 22784712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.
    Niimi H; Harada H; Harada Y; Ding Y; Imagawa J; Inaba T; Kyo T; Kimura A
    Leukemia; 2006 Apr; 20(4):635-44. PubMed ID: 16467864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ras effector loop mutations that dissociate p120GAP and neurofibromin interactions.
    Stang S; Bottorff D; Stone JC
    Mol Carcinog; 1996 Jan; 15(1):64-9. PubMed ID: 8561868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS.
    Reins J; Mossner M; Neumann M; Platzbecker U; Schumann C; Thiel E; Hofmann WK
    Leuk Res; 2010 Dec; 34(12):1610-6. PubMed ID: 20471677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia.
    Lübbert M; Mirro J; Kitchingman G; McCormick F; Mertelsmann R; Herrmann F; Koeffler HP
    Oncogene; 1992 Feb; 7(2):263-8. PubMed ID: 1549347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferation and differentiation of PC12 cells were affected by p21ras GTPase activating proteins and its deletion mutant proteins.
    Nakata H; Watanabe Y
    Biochem Biophys Res Commun; 1996 Jan; 218(2):538-43. PubMed ID: 8561792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of normal and mutant ras proteins in human acute leukemia.
    Shen WP; Aldrich TH; Venta-Perez G; Franza BR; Furth ME
    Oncogene; 1987 May; 1(2):157-65. PubMed ID: 3325880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sam68 association with p120GAP in CD4+ T cells is dependent on CD4 molecule expression.
    Jabado N; Jauliac S; Pallier A; Bernard F; Fischer A; Hivroz C
    J Immunol; 1998 Sep; 161(6):2798-803. PubMed ID: 9743338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic cells and clonally expanded cytotoxic T cells in bone marrow trephines of patients with myelodysplastic syndrome.
    Pülhorn H; Herrmann M; Harms H; Jung A; Baumann I
    Histopathology; 2012 Aug; 61(2):200-11. PubMed ID: 22690734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effector domain mutations dissociate p21ras effector function and GTPase-activating protein interaction.
    Stone JC; Colleton M; Bottorff D
    Mol Cell Biol; 1993 Dec; 13(12):7311-20. PubMed ID: 8246952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal p21Ras/MAP kinase pathway expression and function in PBMC from patients with polycystic ovary disease.
    Buchs A; Chagag P; Weiss M; Kish E; Levinson R; Aharoni D; Rapoport MJ
    Int J Mol Med; 2004 Apr; 13(4):595-9. PubMed ID: 15010862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.
    Follo MY; Mongiorgi S; Bosi C; Cappellini A; Finelli C; Chiarini F; Papa V; Libra M; Martinelli G; Cocco L; Martelli AM
    Cancer Res; 2007 May; 67(9):4287-94. PubMed ID: 17483341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
    Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome.
    Schlesinger M; Silverman LR; Jiang JD; Yagi MJ; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1996; 48(4):149-66. PubMed ID: 9819667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.